Pluri Inc. Share-based Goods and Nonemployee Services Transaction, Capitalized Cost
Pluri Inc. (PLUR) reported Share-based Goods and Nonemployee Services Transaction, Capitalized Cost of $302.00 thousand for the 12-month period ending 2016-06-30, per its 10-K filed 2016-09-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionCapitalizedCost · last filed 2018-09-12
- Pluri Inc. share-based goods and nonemployee services transaction, capitalized cost for the quarter ending 2016-06-30 was $0.00.
- Pluri Inc. share-based goods and nonemployee services transaction, capitalized cost for the quarter ending 2016-03-31 was $0.00.
- Pluri Inc. share-based goods and nonemployee services transaction, capitalized cost for the quarter ending 2015-12-31 was -$27.00K.
- Pluri Inc. share-based goods and nonemployee services transaction, capitalized cost for the quarter ending 2015-09-30 was $329.00K.
- Pluri Inc. share-based goods and nonemployee services transaction, capitalized cost for fiscal 2016 was $302.00K, a 14.83% increase from fiscal 2015.
- Pluri Inc. share-based goods and nonemployee services transaction, capitalized cost for fiscal 2015 was $263.00K.
| Period end | Share-based Goods and Nonemployee Services Transaction, Capitalized Cost 1 month | Share-based Goods and Nonemployee Services Transaction, Capitalized Cost 3 month | Share-based Goods and Nonemployee Services Transaction, Capitalized Cost 6 month | Share-based Goods and Nonemployee Services Transaction, Capitalized Cost 9 month | Share-based Goods and Nonemployee Services Transaction, Capitalized Cost 12 month |
|---|---|---|---|---|---|
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07 | $0.00 derived: sum of 2 quarters · filed 2016-09-07 | -$27.00K derived: sum of 3 quarters · filed 2016-09-07 | $302.00K 10-K · filed 2016-09-07 | |
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09 | -$27.00K derived: sum of 2 quarters · filed 2016-05-09 | $302.00K 10-Q · filed 2016-05-09 | ||
| 2015-12-31 | -$27.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-08 | $302.00K 10-Q · filed 2016-02-08 | |||
| 2015-10-31 | $302.00K 10-K · filed 2018-09-12 | ||||
| 2015-09-30 | $329.00K 10-Q · filed 2015-11-05 | ||||
| 2015-06-30 | $263.00K 10-K · filed 2015-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |